| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 22 |
| 1 | SITAGLIPTIN | 14 |
| 2 | PEMBROLIZUMAB | 9 |
| 3 | SECUKINUMAB | 9 |
| 4 | ALPRAZOLAM | 8 |
| 5 | ASPIRIN | 7 |
| 6 | ASPIRIN 325 MG | 7 |
| 7 | ASPIRIN 81 MG | 7 |
| 8 | CARBOPLATIN | 7 |
| 9 | IPILIMUMAB | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENAZOPYRIDINE HYDROCHLORIDE | 4 | 0.0121 |
| 1 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 2 | ADEFOVIR DIPIVOXIL | 2 | 0.0016 |
| 3 | DROPERIDOL | 2 | 0.0012 |
| 4 | PHENAZOPYRIDINE | 4 | 0.0011 |
| 5 | CALCIUM FOLINATE | 5 | 0.0011 |
| 6 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 7 | CLINDAMYCIN PHOSPHATE | 4 | 0.0007 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 3 | 0.0007 |
| 9 | DAUNORUBICIN HYDROCHLORIDE | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 2 | 0.0003 |
| 1 | 5-alpha Reductase Inhibitor [EPC] | 22 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 7 | 0.0001 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 4 | 0.0001 |
| 5 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 7 | 0.0001 |
| 7 | Phenothiazine [EPC] | 2 | 0.0001 |
| 8 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 9 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |